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Neonatal and maternal outcomes following
midtrimester preterm premature rupture of
the membranes: a retrospective cohort
study
Laura Aoife Linehan1*, Jennifer Walsh1, Aoife Morris1, Louise Kenny1,2, Keelin O’Donoghue1, Eugene Dempsey3
and Noirin Russell1
Abstract
Background: Preterm premature rupture of membranes (PPROM) complicates 1 % of all pregnancies and occurs in
one third of all preterm deliveries. Midtrimester PPROM is often followed by spontaneous miscarriage and elective
termination of ongoing pregnancies is offered in many countries. The aim of this retrospective descriptive cohort
study was to investigate the natural history of midtrimester PPROM in a jurisdiction where termination of pregnancy in
the absence of maternal compromise is unavailable.
Methods: Cases of midtrimester PPROM diagnosed between 14 and 23 + 6 weeks’ gestation during April 2007 to June
2012 were identified following a manual search of all birth registers, pregnancy loss registers, annual reports,
ultrasound reports, emergency room registers and neonatal death certificates at Cork University Maternity
Hospital - a large (circa 8500 births per annum) tertiary referral maternity hospital in southwest Ireland. Cases
where delivery occurred within 24 h of PPROM were excluded.
Results: The prevalence of midtrimester PPROM was 0.1 % (42 cases/44,667 births). The mean gestation at PPROM
was 18 weeks. The mean gestation at delivery was 20 + 5 weeks, with an average latency period of 13 days.
Ten infants were born alive (23 %; 10/42). The remainder (77 %; 32/42) died in utero or intrapartum. Nine infants were
resuscitated. Two infants survived to discharge. The overall mortality rate was 95 % (40/42).
Five women had clinical chorioamnionitis (12 %; 5/42) but 69 % demonstrated histological chorioamnionitis. One
woman developed sepsis (2.4 %; 1/42). Other maternal complications included requirement of intravenous antibiotic
treatment (38 %; 17/42), retained placenta (21 %, 9/42) and post-partum haemorrhage (12 %; 5/42).
Conclusions: This study provides useful and contemporary data on midtrimester PPROM. Whilst fetal and neonatal
mortality is high, long-term survival is not impossible. The increased risk of maternal morbidity necessitates close
surveillance.
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Background
Midtrimester preterm premature rupture of membranes
(PPROM) is an uncommon complication, occurring in
less than 1 % of pregnancies [1]. PPROM is an important
contributor to perinatal mortality and morbidity; in
pregnancies that continue following PPROM at early
gestations, morbidity is high among surviving neonates
with problems including respiratory distress syndrome,
pulmonary hypoplasia, intraventricular haemorrhage and
limb contractures [2]. Pregnancies complicated by
PPROM early in pregnancy, when the risk of pulmonary
hypoplasia is highest, present a counselling and manage-
ment dilemma. It is difficult to predict the eventual out-
come as many factors impact on this – the development
of sepsis, the eventual gestational age at delivery and the
degree of oligohydramnios. There is a wide variety in
chorioamnionitis rates and survival rates quoted in the
literature. Chorioamnionitis ranged from 28 to 42 % [3, 4],
whilst survival rates quoted range from 6.25 [3] to 100 %
[5], dependant on gestation. Advances in neonatal care,
particularly intensive care to those at the threshold of via-
bility, have dramatically enhanced survival rates. These
changes, which reflect a multimodal approach to care,
include advances in newborn stabilisation, surfactant
administration, optimising respiratory support, the use of
nitric oxide and reduction in associated morbidities such
as infection and intraventricular haemorrhage and the use
of probiotics to reduce necrotising enterocolitis (NEC) [6].
There is a paucity of contemporary evidence about the
natural history of these pregnancies as therapeutic ter-
mination of pregnancy is routinely offered as standard
care in many countries. Termination of pregnancy was
not available in Ireland during the time period of this
study. However, the publication of the Protection of Life
during Pregnancy Act in 2013, provided clarification that
termination of pregnancy may be performed if there is a
“real and substantial risk of loss of the woman’s life from
a physical illness” [7]. There remains an absence of clear
guidance if there is no imminent threat to maternal life
or health, even in the case of fatal fetal abnormality or
where prognosis for the fetus is poor.
Thus, in Ireland when PPROM occurs at a pre-viable
gestation but the fetus remains alive, management is
problematic. Parents are counselled regarding the guarded
prognosis and a care plan is established to provide regular
monitoring for the woman. This usually involves regular
fetal heart checks via ultrasound and close surveillance for
signs and symptoms of maternal sepsis. If there is evi-
dence of developing infection, it may be necessary to in-
duce delivery. This is generally done medically using
mifepristone and misoprostol. There is a paucity of infor-
mation with which to counsel parents regarding fetal and
neonatal survival, long term health outcome of surviving
infants and the risk of maternal complications, particularly
chorioamnionitis and sepsis, in these cases following
PPROM at less than 24 weeks’ gestation.
Our objective was to establish the natural history of
midtrimester PPROM. We aimed to establish how many
women in our hospital experienced midtrimester PPROM
and to establish the associated neonatal and maternal
health outcomes. We aimed to provide information to
assist clinicians to accurately counsel women about mater-
nal and fetal risks associated with midtrimester PPROM.
Methods
This study was a retrospective descriptive cohort study. Eth-
ical approval was obtained from The Clinical Research and
Ethics Committee of the Cork Teaching Hospitals in No-
vember 2010, (ref no: ECM 4 (o) 07/12/10), prior to study
commencement. The committee deemed that informed
written or verbal consent was not required. All women who
presented to Cork University Maternity Hospital between
April 2007 and June 2012 with midtrimester PPROM were
included. Midtrimester was defined as 14 + 0 to 23 + 6 weeks’
gestation. Women who delivered within 24 h of rupture of
membranes were not included as we wished to exclude
those with preterm birth without prolonged rupture of
membranes and those where a PPROM is rapidly followed
by a miscarriage. We specifically wished to study those pa-
tients who experience a midtrimester prolonged PPROM
but do not deliver rapidly so that we could best advise this
cohort about the exact risks this poses for them and their
baby. A manual search was performed of all birth registers,
pregnancy loss registers, annual reports, ultrasound reports,
emergency room registers and neonatal death certificates of
Cork University Maternity Hospital from April 2007 to June
2012. Cases of midtrimester PPROM were identified and a
retrospective chart review was performed. In order to
complete data collection on these cases, laboratory and radi-
ology databases were also reviewed.
Our primary outcome measures were gestation at
PPROM, gestation at delivery, latency period, neonatal
survival rate and neonatal and maternal morbidity. The
study was adherent to the STROBE criteria as outlined
in Additional file 1.
Results
We identified 42 cases of ongoing pregnancy after mid-
trimester PPROM during the study period, during which
44,667 births occurred. This gives a prevalence of 0.1 %.
Maternal demographics are outlined in Table 1. A
PPROM was diagnosed when a sterile speculum examin-
ation clearly demonstrated liquor to be present in the
posterior fornix of the vagina. An ultrasound was also
performed to confirm oligohydramnios.
The majority of women had no significant underlying
medical conditions (n = 35). One woman had antipho-
spholipid antibodies, one had hypothyroidism, two women
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had type 2 Diabetes Mellitus with Body Mass Indices
(BMI; kg/m2) of 40 and 45, one woman had multiple scler-
osis, one woman had a PT20210 mutation (an inherited
genetic mutation involving the prothrombin gene which
increases the risk of thrombosis 2–3 fold) and one woman
was HIV positive.
The majority of women (60 %, n = 26) had attended
for a dating ultrasound scan prior to PPROM. The re-
mainder had their first ultrasound scan at diagnosis of
PPROM and dates were assigned via measurement of
the bi-parietal diameter, head circumference and femur
length. Obstetric history is outlined in Table 2. Of note,
7 % (3/42) had experienced prior PPROM, 9.5 % (4/42)
had a prior preterm birth, 4.75 % (2/42) had a previous
midtrimester miscarriage and 7 % (3/42) had a previous
third trimester loss. Three further women experienced
consecutive midtrimester PPROM during the study
period and are included twice.
All women in our study received oral antibiotics, usu-
ally in the form of oral erythromycin. This is in keeping
with the Royal College of Obstetricians and Gynaecolo-
gists (RCOG) Green Top Guideline No. 44 “Preterm
Prelabour Rupture of Membranes” [8] which recom-
mends that erythromycin is given for 10 days following a
diagnosis of PPROM. In this scenario, antibiotics were
prescribed in the maternal interest due to the risk of
sepsis. The majority of women (80 %; 37/42) remained
as inpatients to receive this treatment, with 25 women
(58 %) delivering in this time period. The average length
of stay was 8 nights (range 1–36). Patients received a
weekly ultrasound scan to assess fetal wellbeing. The
average amniotic fluid index at diagnosis of PPROM was
1 cm (range 0–2, n = 12). Antenatal corticosteroids were
routinely administered at 24 weeks gestation. Thirty
women delivered before 24 weeks and did not receive
corticosteroids (range 15 + 6–23 + 3 weeks). Twelve
women received intramuscular dexamethasone (28 %)
and 83 % of these women (10/12) delivered a live infant.
Two of these infants delivered at 23 + 6 weeks. One
infant was not actively resuscitated and the other infant
lived for 21 days. The single long term surviving infant
in this cohort delivered at 23 + 3 weeks after PPROM at
23 + 1 weeks and did not receive antenatal steroids.
One woman presented with symptoms of acute chor-
ioamnionitis and sepsis having experienced PPROM at
home 2 days prior to presentation. She was induced in
the maternal interest at 20 + 5 weeks and remained an
inpatient for intravenous treatment and observation for
3 days, going on to make an uneventful recovery. A placen-
tal swab later indicated Group B streptococcal infection.
Sixteen other women required intravenous antibiotics but
were managed at ward level, without complications.
Twelve percent (n = 5) of women suffered clinical
chorioamnionitis, but histological chorioamnionitis was
found in 69 % of examined placentas. Twenty-five women
had recorded treatment with antibiotics. Fourteen had
oral erythromycin only, 16 required intravenous anti-
biotics, namely benzylpenicillin, co-amoxiclav, metro-
nidazole, clindamycin and gentamicin.
Over 20 % of mothers, (9/42), experienced a retained
placenta following delivery, thus requiring manual re-
moval. Additionally, 13.9 % (6/42) of women had retained
products of conception, four were treated conservatively
with antibiotics and two required a surgical uterine
evacuation. Other maternal complications are outlined
in Table 3. Two women required blood transfusion
related to manual removal of placenta.
The mean gestation at PPROM was 18 weeks (range
15 + 5–23 + 6, n = 37). Five women were unsure of exact
date of PPROM. The average interval from PPROM to
Table 1 Maternal Demographics
Maternal age Average: 32 (Range 19–42,
n = 42)
Race Caucasian 31 (n = 38)
African 7
BMI (kg/m2) Underweight 4 Average BMI 28
Normal 13 (n = 32, range
17–46)
Overweight 8
Obese 5
Morbidly Obese 2
Smoker Pre-pregnancy 9
Pregnancy 4
Alcohol Pregnancy 7 (1–10units/wk.)
Recreational Drug Use None
Table 2 Obstetric History
Gravidity Average 2.6 (range 1–7)
Parity Average 1 (range 0–3)
Primigravidas 12 (29 %)
Prior Preterm Rupture
of Membranes
3 (7 %)
i. 21/40
ii. 27/40
iii. 36/40
Prior Preterm Birth 4 (9.5 %)
i. 35/40 and 36/40 (IOL for IUD)
ii. 28/40
iii. 36/40
iv. 36/40
Intrauterine Death 1 (36/40)
Stillbirth 1 (term)
Neonatal Death 1 (33/40)
Midtrimester Miscarriage 2 (Both at 18/40)
First Trimester Miscarriage 16 (38 %)
• 2 or More 5 (12 %)
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delivery was 13 days (range 1.1–85 days, n = 37) and the
average gestation at delivery was 20 weeks + 5 days
(range 17 + 4–29 + 4, n = 42). The average birth weight
was 614 g (n = 19). Twenty-seven infants had gender re-
corded, 19 male and eight female. Ten infants were born
alive (23 %) with an average birth weight of 740 g (range
440–1100 g) and an average gestational age of 25 +
2 weeks (range 23 + 3–29 + 4). The remainder (76 %; 32/
42) died in utero (n = 4), intrapartum or at birth due to
previability (n = 28). No infants weighing less than 500 g
were resuscitated. When the infants were grouped ac-
cording to age, no infants in whom PPROM was re-
corded to have occurred at less than 17 weeks (n = 11)
survived, three infants in the 17–21 + 6 group (n = 17)
were born alive and seven of the infants where PPROM
occurred after 22 weeks (n = 9) were born alive. Of those
born alive, 90 % (9/10) were resuscitated and admitted
to the neonatal intensive care unit (NICU). Seven re-
ceived surfactant. Six required intravenous antibiotics.
The average length of stay in NICU was 34.6 days (range
2 h–146 days).
Three infants died within 2 h of birth, including the
infant not admitted. One of these infants had been a
PPROM at 17 weeks gestation and delivered at 25 + 3
with pulmonary hypoplasia and limb contractures. The
other two infants had low APGAR scores at delivery and
were treated palliatively without active resuscitation.
Complications affecting neonatal survivors are outlined
in Table 4.
Seven infants survived at least 7 days. Two infants sur-
vived to discharge. Both were female infants. One female
infant was born at 29 + 4 after a latency period of 85 days
weighing 930 g. She was transferred to another paediatric
surgical institution at 20 days of age but subsequently died
of Necrotising Enterocolitis at 8 weeks of age. The surviv-
ing neonate was born to a 24 year old African woman
who was HIV positive. Rupture of membranes occurred at
23 + 1 weeks and delivery was 2 days later at 23 + 3 weeks.
The mother developed oligohydramnios and clinical chor-
ioamnionitis. Treatment of this woman involved oral
erythromycin, oral co-amoxiclav, intravenous gentamicin,
intravenous metronidazole and intravenous ceftriaxone. A
female infant weighing 580 g was delivered. Length of stay
in the neonatal intensive care unit was 146 days. Compli-
cations following birth included respiratory distress syn-
drome, patent ductus arteriosus, patent foramen ovale,
grade two intraventricular haemorrhage and multiple sei-
zures. The infant was discharged home alive with a diag-
nosis of chronic lung disease but is currently a healthy
4 year old who had met all her developmental milestones
on discharge from neonatology follow-up.
After delivery, women were investigated for potential
underlying causes of second trimester loss and also
screened for infection. These investigations included
blood counts, high vaginal swabs, mid-stream urinalysis,
placental swabs, serology for cytomegalovirus, toxo-
plasma, syphilis, rubella and parvovirus B19, thyroid
function tests, thrombophilia and autoantibody screens.
Cytogenetics, post mortem and placental histological
examination were also offered. All women were followed
up postnatally in the pregnancy loss clinic to discuss
their pregnancy events and outcome, to follow up on
investigations and to formulate a management plan for
subsequent pregnancies. They were also supported by
the specialist midwifes in bereavement and loss and
offered formal counselling support where desired.
Placental histology was available in 32 cases. Although
only five women had clinical symptoms of chorioamnio-
nitis (12 %; 5/42) there was histological chorioamnionitis
in 69 % of examined placentas (22/42). Two further pla-
centas demonstrated retroplacental haemorrhage and one
demonstrated haemorrhagic infarction. The remainder
were reported as normal (17 %; 7/42). Nine infants had
cytogenetic analysis which all demonstrated normal karyo-
types. Three infants underwent post mortem examination.
These demonstrated anatomically normal infants.
Twenty-eight women (67 %) had high vaginal swabs-
two swabs cultured group B streptococcus. Twenty
women (48 %) had mid-stream urine samples sent, none
of which demonstrated significant infection. Seven women
(17 %) had placental swabs taken – one cultured group B
streptococcus. Only the woman who developed sepsis had
blood cultures taken.
Discussion
The incidence of midtrimester PPROM was 1 in 1000
pregnancies. The mean gestational age at presentation
Table 3 Other Maternal Complications
Non-Substantial Ante-Partum
Haemorrhage(NSAPH) Prior
To PPROM
18 (42 %)
Haemorrhage Following PPROM 18 (42 %)
Suspected Abruption 1 (Emergency Caesarean
Delivery At 23 + 3)
Post-Partum Haemorrhage 5 (12 %)
Blood Transfusion 3 (7 %)
Table 4 Neonatal Complications
Respiratory Distress Syndrome 7 (70 %, 100 % of those
surviving beyond 2 h)
Sepsis 3 (30 %)
Coagulase Negative Staphylococcal
(CONS) Sepsis
2 (20 %)
Patent Ductus Arteriosus (PDA) 4 (40 %)
Necrotising Enterocolitis (NEC) 2 (20 %)
Intraventricular Haemorrhage(IVH) 3 (30 %)
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was 18 weeks and the mean interval to delivery was
13 days. The average age at delivery in our study was 20 +
5, which is remote from viability. The average birth weight
was 614 g. Thus survival in this cohort was very unlikely.
Thirty-two infants (76 %) died in utero (4/42) or peripar-
tum due to previability (28/42). Ten infants were born
alive (23 %; 10/42) with an average birth weight of 740 g
(range 440–1100 g) and an average gestational age of 25 +
2 weeks (range 23 + 3–29 + 4). Ninety percent (9/10) of
these were actively managed and taken to the NICU. Six
of these infants died in the NICU of sepsis, IVH or RDS,
hence the overall survival to discharge was 4.76 % (2/42).
No infants in whom PPROM was recorded to have
occurred at less than 17 weeks (n = 11) survived, three in-
fants in the 17–21 + 6 group (17 %, n = 17) were born alive
and seven of the infants where PPROM occurred after
22 weeks (78 %, n = 9) were born alive. Maternal morbid-
ity was low, despite the prolonged latency period and the
lack of availability of termination or delivery on maternal
request. The incidence of clinical chorioamnionitis was
low (14 %; 6/42) but high histologically suggesting a high
index of suspicion is required with these women. Whilst
17 women required antibiotics, only one woman devel-
oped sepsis. This suggests that it is reasonable to offer
women conservative management of PPROM, once they
are carefully monitored for signs of sepsis. Although neo-
natal survival rates are low, women may choose this as a
more acceptable alternative to termination of pregnancy.
This study was distinctive in examining PPROM at
early gestations. There are few studies examining the
outcomes of these pregnancies. Additionally, we provide
a unique perspective as elective termination of pregnancy
is not routinely offered in Ireland for this indication in the
absence of maternal compromise. This study provides sig-
nificant information on the natural history of PPROM and
vital information with which to counsel future affected
women.
This is a small retrospective study that refers to a sin-
gle institutional experience, thus our study is limited by
the retrospective nature of data retrieval and the small
number of cases available. Furthermore, a proportion of
women in our study (5/42) were unsure as to the exact
date of PPROM. Thus we must consider unrecognised
PPROM may present as preterm labour or late miscar-
riage and may have been missed in our search. Similarly,
late presentations close to viability may have been
missed as duration of PPROM was not always well docu-
mented in this cohort. These groups may have yielded
survivors.
Other studies have included women experiencing
PPROM at much later gestations up to 34 weeks [9]. In-
deed, this often accounts for their larger sample size
(range 16–236) [3, 10]. Similarly as the infants in our
study were born at earlier gestations, their survival rate
was also lower than other studies. A study by Manuck et
al. also examined women experiencing PPROM between
14 and 23 + 6 weeks [11]. Their study was conducted
over 6 years however with a larger cohort of 159 pa-
tients, presenting at a later mean gestational age (21 + 3)
and delivering at a later mean gestation of 24 + 5 and in-
cluded those delivering 12 h after PPROM. Indeed
shorter latency periods and later gestational age may
have contributed to the increased survival rate of 56 %.
Holmgren et al. found a survival rate of 86 %, but in-
cluded women who experienced PPROM between 14 + 0
and 32 + 0 weeks [12]. There were lower survival rates in
all studies in the earlier PPROM cases but there was a
wide variance in figures. Verma et al. had a survival rate
of 18.3 % but examined pregnancies where PPROM oc-
curred between 18 and 23 weeks only [13]. Conversely,
Loeb et al. included pregnancies complicated by PPROM
between 20 and 24 weeks gestation and found an overall
survival rate of 6.25 % [3]. Survival was 40, 92 and
100 % of those experiencing PPROM at 14–19, 20–25
and 26–28 weeks respectively by Farooqi et al. [5]. Like-
wise, Newman et al. found a mortality of 98.8 % in
PPROM occurring at 23–24 weeks which fell to 36.6 %
in the 25–27week group [10]. Xiao reported a similarly
high mortality rate of 82 % in their PPROM cases at less
than 22 weeks gestation (14–21.9 weeks) [14]. Margato
et al. also found that PPROM occurring at gestations less
than 20 weeks had a lower survival rate [15]. This is
consistent with our own findings which showed a 100 %
mortality rate in those with PPROM at less than
17 weeks, but 78 % of infants experiencing PPROM after
22 weeks were born alive. Latency periods also varied
widely (1.25 – 105 days) [2]. The consensus was that
longer latency periods had a positive impact on survival,
allowing time for corticosteroid administration and
antibiotics, but equally increased the risk of chor-
ioamnionitis [5, 13].
Chorioamnionitis rates in our study were lower than
others at 13 %. Rates in other studies ranged from 28 to
42 % [4, 5]. Similarly, Loeb described a much higher in-
cidence of histological versus clinical chorioamnionitis
(85 % vs 39 %) [3]. There was a 20 % incidence of
retained placenta. This is much higher than Verma et al.
who reported an incidence of retained placenta of
9.09 % [13]. Of the women with retained placenta, four
had histological chorioamnionitis (44 %, 4/9) and one
had clinical signs of chorioamnionitis (11 %, 1/9). The
remaining women (n = 4) did not have placental histology
available. There appeared to be no association between
latency period and retained placenta. With the exception
of one woman with a latency period of 85 days, the re-
mainder had an average latency of 4.2 days (n = 5, r = 2–7).
Neonatal complications were comparable to other
studies. All infants transferred to the NICU had significant
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respiratory morbidity and were managed with mechanical
ventilation, nitric oxide and surfactant. Verma et al.
reported a similar finding with an incidence of RDS
of 100 % [13]. Dinsmoor et al. reported sepsis among
34 % of subjects consistent with our rate of 30 % [1].
IVH occurred in 30 % of our cohort, two of which
were grade 4. Other studies reported lower rates of
severe IVH [1, 4, 13]. Most studies conceded that neonatal
morbidity was high in this cohort and was often serious,
with at least one major morbidity present in the range of
37 to 100 % [1, 2, 4, 11–14] of those infants surviving to
discharge. Our single survivor had four major complica-
tions of prematurity and continues to have respiratory
complications, emphasising the importance of antenatal
steroids near viability. This places our survival rate of in-
fants born alive at just 10 %, similar to Loeb but lower than
other authors who found survival rates of 67–81 % [3, 12].
Conclusion
In summary our study shows that PPROM prior to via-
bility is a rare complication of pregnancy, but one that
carries significant fetal and maternal risks. By focusing
on these women of earlier gestation we provide useful
data for pregnant women and clinicians regarding these
challenging cases. It is clear however that further work
needs to be done in this area, involving larger numbers
and a collaboration of experience from multiple institu-
tions. There was an inconsistency of investigations, par-
ticularly in screening for infection on initial presentation.
The introduction of a new national guideline on PPROM
[16] and the Irish Maternity Early Warning System (I-
MEWS) [17] should help to improve initial management
as well as detection and prevention of sepsis. Future stud-
ies should focus on the impact of these measures.
Whilst our overall survival rate was 5 %, 78 % of foe-
tuses in those pregnancies where the PPROM occurred
after 22 weeks were born alive. Counselling must be
frank regarding the poor prognosis of those remote from
viability, but awareness of increasing fetal potential with
enduring latency periods should encourage the clinician
caring for this challenging cohort. Additionally, advances
in neonatal care and therapies such as amnioinfusion or
amniopatch may offer increased hope of survival in the
future [18]. Acknowledging the risk to mother and fetus
from infection should instigate due diligence in seeking
signs and symptoms of sepsis. Recent changes to Irish
legislation add another dimension to counselling and de-
cisions surrounding delivery in the maternal interest in
cases of acute chorioamnionitis [7, 16].
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